We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGY icon
2076
Magnolia Oil & Gas
MGY
$5.94B
$1.15M ﹤0.01%
162,721
+9,254
+6% +$55.2K
KRRO icon
2077
Korro Bio
KRRO
$195M
$1.15M ﹤0.01%
650
+34
+6% +$44.9K
NKTX icon
2078
Nkarta
NKTX
$172M
$1.14M ﹤0.01%
18,597
+3,199
+21% +$133K
OIS icon
2079
Oil States International
OIS
$491M
$1.14M ﹤0.01%
227,310
+30,174
+15% +$117K
TCRR
2080
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1.14M ﹤0.01%
36,884
+6,433
+21% +$163K
UTL icon
2081
Unitil
UTL
$980M
$1.14M ﹤0.01%
25,739
+5,032
+24% +$201K
RDUS
2082
DELISTED
Radius Health, Inc.
RDUS
$1.14M ﹤0.01%
63,538
+2,683
+4% +$40.3K
HBNC icon
2083
Horizon Bancorp
HBNC
$1.04B
$1.13M ﹤0.01%
71,316
+8,890
+14% +$122K
ATRS
2084
DELISTED
Antares Pharma, Inc.
ATRS
$1.12M ﹤0.01%
280,816
+19,855
+8% +$64.2K
AIV
2085
Aimco
AIV
$383M
$1.11M ﹤0.01%
211,141
-2,094,469
-91% -$9.3M
CNST
2086
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.11M ﹤0.01%
38,550
+2,454
+7% +$61.8K
FF icon
2087
Future Fuel
FF
$223M
$1.1M ﹤0.01%
86,818
+7,799
+10% +$94.2K
NVEC icon
2088
NVE Corp
NVEC
$609M
$1.1M ﹤0.01%
19,614
-129
-0.7% -$6.63K
LBRT icon
2089
Liberty Energy
LBRT
$3.25B
$1.1M ﹤0.01%
106,766
+16,796
+19% +$153K
CCRN
2090
DELISTED
Cross Country Healthcare
CCRN
$1.1M ﹤0.01%
124,052
+12,854
+12% +$105K
ATNX
2091
DELISTED
Athenex, Inc. Common Stock
ATNX
$1.1M ﹤0.01%
4,966
+296
+6% +$72.9K
SITM icon
2092
SiTime
SITM
$21.8B
$1.09M ﹤0.01%
9,762
+1,239
+15% +$117K
DHT icon
2093
DHT Holdings
DHT
$3.02B
$1.09M ﹤0.01%
208,058
+22,201
+12% +$116K
COWN
2094
DELISTED
Cowen Inc. Class A Common Stock
COWN
$1.08M ﹤0.01%
41,750
+473
+1% +$10.7K
MCS icon
2095
Marcus Corp
MCS
$945M
$1.08M ﹤0.01%
80,452
+9,291
+13% +$94.1K
OMER icon
2096
Omeros
OMER
$959M
$1.08M ﹤0.01%
75,796
+6,239
+9% +$76.2K
NEX
2097
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$1.08M ﹤0.01%
314,454
+34,248
+12% +$91.3K
ARCT icon
2098
Arcturus Therapeutics
ARCT
$211M
$1.08M ﹤0.01%
24,833
+7,969
+47% +$540K
ECHO
2099
EchoStar
ECHO
$26.2B
$1.07M ﹤0.01%
50,548
-946
-2% -$22.6K
IVC
2100
DELISTED
Invacare Corporation
IVC
$1.07M ﹤0.01%
119,632
+13,690
+13% +$114K

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.